These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24037995)

  • 41. Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis.
    Ringe JD; Miethe D; Pittrow D; Wegscheider K
    Arzneimittelforschung; 2003; 53(7):496-502. PubMed ID: 12918215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Green urine following exposure to flupirtine.
    Maier A; Liu Y; Scholze A; Westhoff TH; Tepel M
    Am J Kidney Dis; 2010 Nov; 56(5):1014-5. PubMed ID: 20970027
    [No Abstract]   [Full Text] [Related]  

  • 44. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
    Cicero TJ; Inciardi JA; Muñoz A
    J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analytic models to identify patients at risk for prescription opioid abuse.
    White AG; Birnbaum HG; Schiller M; Tang J; Katz NP
    Am J Manag Care; 2009 Dec; 15(12):897-906. PubMed ID: 20001171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Addictive behaviors and benzodiazepines: 1. Abuse liability and physical dependence.
    Senay EC
    Adv Alcohol Subst Abuse; 1989; 8(1):107-24. PubMed ID: 2565664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for physical and behavioral dependence on non-opioid analgesics in a German elderly hospital population.
    Bonnet U; Strasser JC; Scherbaum N
    Addict Behav; 2019 Mar; 90():265-271. PubMed ID: 30472534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical experience with flupirtine in the U.S.
    McMahon FG; Arndt WF; Newton JJ; Montgomery PA; Perhach JL
    Postgrad Med J; 1987; 63 Suppl 3():81-5. PubMed ID: 3328854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.
    Schifano F; Chiappini S
    PLoS One; 2018; 13(10):e0204443. PubMed ID: 30286103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of risk minimization measures on compliance and prescribing practices of flupirtine in Germany.
    Kaplan S; Ehlken B; Hamann X
    Curr Med Res Opin; 2019 Jan; 35(1):33-40. PubMed ID: 29992843
    [No Abstract]   [Full Text] [Related]  

  • 51. [Thirty years of nefopam abuse in France].
    Revol B; Delorme J; Jouanjus É; Spadari M; Djezzar S; Lepelley M; Khouri C; Fouilhé Sam-Laï N; Mallaret M;
    Therapie; 2021; 76(6):527-537. PubMed ID: 33618914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is There a Potential of Misuse for Venlafaxine and Bupropion?
    Schifano F; Chiappini S
    Front Pharmacol; 2018; 9():239. PubMed ID: 29618978
    [No Abstract]   [Full Text] [Related]  

  • 53. [Long-term-treatment of chronic pain patients with flupirtine--on hepatotoxicity and persistent effectiveness from 7 months to 22 years].
    Wörz R
    MMW Fortschr Med; 2014 Dec; 156 Suppl 4():127-34. PubMed ID: 26153592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Flupirtine helps - but pay attention to the liver!].
    Kreutzkamp B
    Med Monatsschr Pharm; 2015 Apr; 38(4):149-50. PubMed ID: 26364387
    [No Abstract]   [Full Text] [Related]  

  • 55. Propylhexedrine: a vintage drug of abuse, rediscovered.
    Fernandez Julia P; Francis EM
    J Psychoactive Drugs; 2012; 44(3):277-9. PubMed ID: 23061329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use abusive of benzydamine in Brazil: an overview in pharmacovigilance].
    Mota DM; Costa AA; Teixeira Cdos S; Bastos AA; Dias MF
    Cien Saude Colet; 2010 May; 15(3):717-24. PubMed ID: 20464184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use and abuse of non-narcotic analgesics.
    Ladewig D; Miest PC; Dubach UC; Ettlin C; Hobi V
    Drug Alcohol Depend; 1978 Nov; 3(6):435-42. PubMed ID: 720212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corticosteroid abuse revisited.
    Goldberg RL; Wise TN
    Int J Psychiatry Med; 1986-1987; 16(2):145-9. PubMed ID: 3744683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Addiction liability of analgesics: tests and results.
    EDDY NB
    J Am Geriatr Soc; 1956 Feb; 4(2):177-86. PubMed ID: 13295022
    [No Abstract]   [Full Text] [Related]  

  • 60. German research network 'Analytical Epidemiology of Substance Abuse' (ANEPSA).
    Eur Addict Res; 1998 Dec; 4(4):203-4. PubMed ID: 9852373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.